Unicycive Therapeutics Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Unicycive Therapeutics Inc. | UNCY - NASDAQ |
$5.00-$6.00 | $5.00 | $8.55 | 5 million | 7/13/2021 |
| Roth Capital | ||||||
Co-Manager(s): Kingswood Capital
| ||||||
| Health Care | ||||||
Filing(s): Filed 2021-05-21 Terms Added 2021-06-07 Terms Changed 2021-06-21 Terms Changed 2021-06-30 | ||||||
Unicycive Therapeutics Inc. Quote & Chart - Click for current quote - UNCY
IPO Boutique aggregates information on public companies and private companies, such as "UNCY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Unicycive Therapeutics Inc. (adapted from Unicycive Therapeutics Inc. prospectus):
They are a biotechnology company dedicated to developing treatments for certain medical conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a biotechnology company dedicated to developing treatments for certain medical conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "UNCY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.